GlassScriptPhysician profile
Michael T Kelley
NPI 1073571816
$424.68
in general payments reported to CMS, 2019-2025
7 companies · $102 in 2025
The $102 reported for 2025 was less than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $135 · 2023: $167 · 2024: $21.62 · 2025: $102.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $290.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $289.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $137.14 | 2023 | Penta |
| Fx Shoulder Solutions, INC | $134.77 | 2021 | |
| Bioventus LLC | $56.60 | 2025 | Xcell, Durolane |
| Collegium Pharmaceutical, INC. | $29.42 | 2023 | Xtampza |
| Vertex Pharmaceuticals Incorporated | $24.22 | 2025 | |
| Viiv Healthcare Company | $21.62 | 2024 | Cabenuva, Apretude |
| Novo Nordisk INC | $20.91 | 2025 | Wegovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Kelley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.